KRS Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

KRS Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$251K	Sell
2024 Q2	$237K	Buy
2024 Q1	$241K	Buy
2023 Q4	$224K	Buy
2023 Q3	–	Sell
2023 Q2	$228K	Buy
2023 Q1	–	Sell
2022 Q4	$210K	Buy
2022 Q1	–	Sell
2021 Q4	$62K	Buy